Spectrofluorimetric assessment of metoclopramide hydrochloride using terbium doped in PMMA matrix optical sensor

Journal of Fluorescence

Volumn 21, Issue 2, 2011, Pages 739-745

  Attia, M S ^a   Othman, A M ^b   Elraghi, E ^b   Aboul Enein, Hassan Y ^c  

^a Ain Shams University   (Egypt)

^b MENOUFIA UNIVERSITY   (Egypt)

^c NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Energy transfer; Luminescence Intensity; Metoclopramide hydrochloride; Optical sensor; PMMA; Terbium

Indexed keywords

AVERAGE RECOVERY; CALIBRATION CURVES; CONCENTRATION RANGES; DETECTION LIMITS; EMISSION BANDS; EMISSION INTENSITY; FLUORESCENCE INTENSITIES; FOREIGN IONS; HUMAN SERUM; ION ASSOCIATES; LINEAR RESPONSE; LUMINESCENCE INTENSITY; METOCLOPRAMIDE; PHARMACEUTICAL PREPARATIONS; PMMA; PMMA MATRICES; SPECTROFLUORIMETRIC; SPECTROFLUORIMETRIC METHODS; STANDARD DEVIATION;

BODY FLUIDS; ENERGY TRANSFER; IONS; LUMINESCENCE; METHANOL; OPTICAL SENSORS; PH EFFECTS; RECOVERY; TERBIUM;

STATISTICS;

DRUG; METOCLOPRAMIDE; POLY(METHYL METHACRYLATE); TERBIUM;

ABSORPTION; ARTICLE; CHEMISTRY; HUMAN; LIGHT RELATED PHENOMENA; LIMIT OF DETECTION; METHODOLOGY; SPECTROFLUOROMETRY; STATISTICAL MODEL;

ABSORPTION; HUMANS; LIMIT OF DETECTION; LINEAR MODELS; METOCLOPRAMIDE; OPTICAL PROCESSES; PHARMACEUTICAL PREPARATIONS; POLYMETHYL METHACRYLATE; SPECTROMETRY, FLUORESCENCE; TERBIUM;

EID: 80053120001     PISSN: 10530509     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10895-010-0764-4     Document Type: Conference Paper

References (29)

1. Tas C, Ozkan CK, Savaser A, Ozkan Y, Tasdemir U, Altunay H (2006) Eur J Pharm Biopharm 64:246-254
2. Buna M, Aaron JJ, Prognon P, Mahuzier G (1996) Analyst 121:1551-1556
3. Revanasiddappa HD, Manju B (2001) J Pharm Biomed Anal 25:631-638
4. Raghuveer S, Rao BE, Sricasteva CMR, Vatsa DK (1992) East Pharm 35:125-144
5. British Pharmacopoeia (1998) Her Majesty's Stationery Office, London
6. Chmielewska A, Konieczna L, Plenis A, Lamparczyk H (2006) J Chromatogr B 839:102-111
7. Royo-Herrero M, Mellado-Romero A, Martinez-Calatayud J (1998) Talanta 47:223-228
8. Moussa BA (2000) J Pharm Biomed Anal 23:1045-1055
9. Fan J, Wang AJ, Feng SL, Wang JJ (2005) Talanta 66:236-243
10. Editorial Committee of the Pharmacopoeia of People's Republic of China, The Pharmacopoeia of People's Republic of China (2000) Chemical Industry Press, Beijing, p. 144
11. Radwan MA (1998) Anal Lett 31:2397-2405
12. Venkateshwaran TG, Kimng DT, Stewart JT (1995) J Liq Chromatogr Relat Technol 18:117-126
13. Foda NH (1994) Anal Lett 27:549-559
14. El-Sayed YM, Khidr SH, Niazy EM (1994) Anal Lett 27:55-70
15. The United States Pharmacopoeia (2000) XXIV Revision, The Nation Formulary XIX Rockville, USP Convention
16. Chang YS, Ku YR, Wen KC, Ho LK (2000) J Liq Chromatogr Relat Technol 23:2009-2019
17. Kerr R, Jung L (1990) Spectra 2000 Deux-Mille. 18:33-34
18. Poban CV, Frutos P, Lastres JL, Frutos G (1996) J Pharm Biomed Anal 15:131-138
19. Riggs KW, Szeitz A, Rurak DW, Multib AE, Abbott FS, Axelson JL (1994) J Chromatogr B Biomed Appl 660:315-325
20. Mostafa GAE (2003) J Pharm Biomed Anal 31:515-521
21. Wang ZH, Zhang HZ, Zhou SP, Dong WJ (2001) Talanta 53:1133-1138
22. Norouzi P, Ganjali MR, Matloobi P (2005) Electrochem Commun 7:333-338
23. Farghaly OA, Taher MA, Naggar AH, El-Sayed AY (2005) J Pharmaceut Biomed Anal 38:14-20
24. Hanna GM, Lau-Cam CA (1991) Drug Dev Ind Pharm 17:975-980
25. Al-Arfaj NA (2004) Talanta 62:255-263
26. Hun X, Zhang Z (2008) J Pharm Biomed Anal 47:670-676
27. Attia MS, Khalil MMH, Ayman A, Abdel-Shafi GM, Salvatore F, Giuseppe C, Finocchiaro P, Abdel-Mottaleb MSA (2007) Int J Photoenergy, ID 12530. doi:10.1155/2007/12530
28. Files LA, Hirschy LM, Winefordner JD (1985) J Pharm Biomed Anal 3:95-100
29. Suleiman MS, Najib NM, El-Sayed YM, Badwan A (1989) Analyst 114:365-368